Instrumento Inactivo

Otros idiomas Nutralife Biosciences Inc Other OTC

Acciones

US67091B1044

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update and Announces the Acquisition of Healthcare Concierges USA	01/03/23
NUTRALIFE BIOSCIENCES, INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	28/02/23
NutraLife BioSciences, Inc. (OTCPK : NLBS) entered into a Stock Exchange Agreement to acquire Healthcare Concierges USA, Inc. from Mrugesh Patel, Pinal Kerai and Aysha Khan for 2 million.	28/02/23
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	21/11/22
NutraLife BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22
NutraLife Biosciences (OTC: NLBS) Releases Q4 2022 Shareholder Update	17/11/22
NutraLife Biosciences Launches a Clinically Tested Focus Stimulant Under a Master Distribution Agreement	27/10/22
NutraLife Biosciences, Inc. Executes Master Distribution Agreement with Whole Foods Full Spectrum Processing	27/10/22
NUTRALIFE BIOSCIENCES, INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	12/10/22
NutraLife BioSciences, Inc. announced that it has received $0.04 million in funding	12/09/22
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22/08/22
NutraLife BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22/08/22
NUTRALIFE BIOSCIENCES, INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	17/08/22
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro	08/07/22
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro	08/07/22
NutraLife Biosciences Inc. Engages CFN Media to Reach, Attract Retail, Accredited & Institutional Investors	15/06/22
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23/05/22
NutraLife BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/05/22
NUTRALIFE BIOSCIENCES, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	11/04/22
NutraLife BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	11/04/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Nutralife Biosciences Inc Other OTC

Acciones

US67091B1044

Otros idiomas

Filtros